Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsReiterationPrice Target
Cantor Fitzgerald analyst Brett Knoblauch reiterates Core Scientific (NASDAQ:CORZ) with a Overweight and maintains $39 price target.
Cantor Fitzgerald analyst Brett Knoblauch reiterates Core Scientific (NASDAQ:CORZ) with a Overweight and maintains $39 price target.